Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00381043 · ClinicalTrials.gov registry record · Phase 4
Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic
A Phase 4 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT00381043 is a Phase 4 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 100 participants.
The verdict
NCT00381043, a Phase 4 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
This is a study of a medication, acamprosate, which is an FDA approved medication for alcohol problems. We will be examining whether acamprosate compared to a sugar pill (placebo) is more effective for helping with drinking in a Family Medicine clinic.
Interventions
- DRUG Acamprosate (Campral)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2006-08 |
| Est. Completion | 2008-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00381043
The ClinicalTrials.gov registry entry for NCT00381043 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acamprosate (Campral) is the first listed.
NCT00381043 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00381043 about?
NCT00381043 is a clinical study titled "Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic". This is a study of a medication, acamprosate, which is an FDA approved medication for alcohol problems. We will be examining whether acamprosate compared to a sugar pill (placebo) is more effective for helping with drinking in a Family Medicine clinic.
What is the current status of trial NCT00381043?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2006-08. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00381043?
The interventions under investigation include: Acamprosate (Campral) (DRUG).
Who is sponsoring clinical trial NCT00381043?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.